With effect from 1 January 2026, the Medicines Evaluation Board (MEB) will be increasing its fees. This increase is necessary due to wage and price developments. For the Veterinary Medicinal Products Unit (VMPU), the increase will be 5.8%. The fees that will take effect on 1 January 2026 will be included in the revised Veterinary Medicinal Products Regulations 2022.
The VMPU charges for the work that it performs. For example, fees are charged for the application and change procedures relating to the issuing of marketing authorisations and production and distribution licences for veterinary medicinal products. Marketing authorisation holders also pay an annual fee for each marketing authorisation they hold. A product type is linked to each fee.
The VMPU overview of fees and product types lists the current fees as well as the fees that will take effect on 1 January 2026.
More information
If you have any questions as a result of this message, please submit them to the VMPU using our contact form.